Human IgG antibody Laboratories manufactures the dental treats spikes reagents distributed by Genprice. The Dental Treats Spikes reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S. Other Dental products are available in stock. Specificity: Dental Category: Treats Group: Spikes
Human true insulin,TI ELISA Kit |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Spikes information
Spike S1 (16-685), Fc Fusion, Avi-tag (SARS-CoV-2) |
100719-1 |
BPS Bioscience |
100 µg |
EUR 320 |
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=104 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Spike S1 (16-685), Fc Fusion, Avi-tag (SARS-CoV-2) |
100719-2 |
BPS Bioscience |
1 mg |
EUR 2720 |
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=104 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
RB,850CM,EASY GRIP,NON TREATED,PS,S,IND,1/40 |
431644 |
CORNING |
1/pk |
EUR 696 |
Description: Roller Bottles; Corning Roller Bottles |
Sample Treatment Plate |
F402 |
Cygnus Technologies |
1x 96 wells plate |
EUR 123.6 |
|
Description: Sample Treatment Plate by Cygnus Technologies is available in Europe via Gentaur. |
Sample Treatment Buffer |
F175 |
Cygnus Technologies |
1000 ml |
EUR 493.2 |
|
Description: Sample Treatment Buffer by Cygnus Technologies is available in Europe via Gentaur. |
Sample Treatment Buffer |
F175-100 |
Cygnus Technologies |
100 ml |
EUR 262.8 |
|
Description: Sample Treatment Buffer by Cygnus Technologies is available in Europe via Gentaur. |
SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag |
E80021 |
EpiGentek |
|
|
SARS-CoV-2 (COVID-19) Spike 156-157EF Antibody |
9685-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: SARS-CoV-2 delta variant, a variant of concern (VOC), known as B.1.617.2, was detected in India in October of 2020. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 99% of the cases. This variant carries at least 13 mutations in spike protein across the sub lineages, including L452R, D614G, P681R and K417N, which can increase the affinity to the human ACE2 receptor. Enhanced transmission of the Delta variant was observed globally, which is at least 2.5 times more contagious as the other variants. The Delta variant affects the effectiveness of COVID19 vaccine and is resistant to neutralization to some extent. |
SARS-CoV-2 (COVID-19) Spike 156-157EF Antibody |
9685-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: SARS-CoV-2 delta variant, a variant of concern (VOC), known as B.1.617.2, was detected in India in October of 2020. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 99% of the cases. This variant carries at least 13 mutations in spike protein across the sub lineages, including L452R, D614G, P681R and K417N, which can increase the affinity to the human ACE2 receptor. Enhanced transmission of the Delta variant was observed globally, which is at least 2.5 times more contagious as the other variants. The Delta variant affects the effectiveness of COVID19 vaccine and is resistant to neutralization to some extent. |
SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag |
E80020 |
EpiGentek |
|
|
SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag |
E80022 |
EpiGentek |
|
|
Spike S1 (B.1.351), Avi-His-Tag (SARS-CoV-2) |
100992-1 |
BPS Bioscience |
100 µg |
EUR 320 |
Description: Recombinant SARS-CoV-2 Spike protein, S1 subunit encompassing amino acids 16-685. This protein corresponds to SARS-CoV-2 Variant B.1.351 originally identified in South Africa and contains mutations L18F, D80A, D215G, R246I, K417N, E484K, N501Y, D614G. It also contains a C-terminal Avi-Tag™ followed by a C-terminal His-tag (6xHis). The recombinant protein is ≥90% pure following affinity purification. |
Spike S1 (B.1.351), Avi-His-Tag (SARS-CoV-2) |
100992-2 |
BPS Bioscience |
1 mg |
EUR 2850 |
Description: Recombinant SARS-CoV-2 Spike protein, S1 subunit encompassing amino acids 16-685. This protein corresponds to SARS-CoV-2 Variant B.1.351 originally identified in South Africa and contains mutations L18F, D80A, D215G, R246I, K417N, E484K, N501Y, D614G. It also contains a C-terminal Avi-Tag™ followed by a C-terminal His-tag (6xHis). The recombinant protein is ≥90% pure following affinity purification. |